2,432
Participants
Start Date
October 1, 2014
Primary Completion Date
March 16, 2015
Study Completion Date
June 23, 2015
FluLaval™ Quadrivalent
1 or 2 doses administered intramusculary (IM) in deltoid region of non-dominant arm (for subjects ≥12 months of age) or anterolateral region of left thigh (for subjects \<12 months of age) on Day 0 (primed subjects) and on Day 0 and Day 28 (unprimed subjects), respectively
Fluzone® Quadrivalent
1 or 2 doses administered IM in deltoid region of non-dominant arm (for subjects ≥12 months of age) or anterolateral region of left thigh (for subjects \<12 months of age) on Day 0 (primed subjects) and on Day 0 and Day 28 (unprimed subjects), respectively
GSK Investigational Site, Syracuse
GSK Investigational Site, Binghamton
GSK Investigational Site, Hermitage
GSK Investigational Site, Erie
GSK Investigational Site, Sellersville
GSK Investigational Site, Philadelphia
GSK Investigational Site, Columbia
GSK Investigational Site, Charlottesville
GSK Investigational Site, Raleigh
GSK Investigational Site, Charleston
GSK Investigational Site, Cheraw
GSK Investigational Site, Lake Mary
GSK Investigational Site, Miami Lakes
GSK Investigational Site, Birmingham
GSK Investigational Site, Dothan
GSK Investigational Site, Kingsport
GSK Investigational Site, Louisville
GSK Investigational Site, Cleveland
GSK Investigational Site, Dayton
GSK Investigational Site, Beavercreek
GSK Investigational Site, Marshfield
GSK Investigational Site, St Louis
GSK Investigational Site, San Nicolás de los Garza
GSK Investigational Site, Topeka
GSK Investigational Site, Augusta
GSK Investigational Site, Newton
GSK Investigational Site, Wichita
GSK Investigational Site, Lincoln
GSK Investigational Site, Lincoln
GSK Investigational Site, Lincoln
GSK Investigational Site, Metairie
GSK Investigational Site, Bossier City
GSK Investigational Site, Jonesboro
GSK Investigational Site, Fort Worth
GSK Investigational Site, Tomball
GSK Investigational Site, Austin
GSK Investigational Site, Colorado Springs
GSK Investigational Site, Colorado Springs
GSK Investigational Site, Nampa
GSK Investigational Site, Layton
GSK Investigational Site, Orem
GSK Investigational Site, Roy
GSK Investigational Site, South Jordan
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Provo
GSK Investigational Site, Payson
GSK Investigational Site, Tucson
GSK Investigational Site, Las Vegas
GSK Investigational Site, Paramount
GSK Investigational Site, Chino
GSK Investigational Site, West Covina
GSK Investigational Site, Anaheim
GSK Investigational Site, Fresno
GSK Investigational Site, Daly City
GSK Investigational Site, Hayward
GSK Investigational Site, Pleasanton
GSK Investigational Site, Walnut Creek
GSK Investigational Site, Oakland
GSK Investigational Site, Santa Clara
GSK Investigational Site, Sacramento
GSK Investigational Site, Sacramento
GSK Investigational Site, Sacramento
GSK Investigational Site, Ellensburg
GSK Investigational Site, Woburn
GSK Investigational Site, Galveston
GSK Investigational Site, Mexico City
Lead Sponsor
GlaxoSmithKline
INDUSTRY